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Introduction
The largest epidemic facing mankind today is human 
immunodeficiency virus (HIV) infection.[1] Sub-Saharan 
Africa, the hardest hit region, is home to more than 
two-thirds (69%) of people living with HIV but only about 
12% of the world’s population.[2] Nigeria still has the largest 
HIV prevalence among pregnant women, ranging from as low 
as 1.6% in the west, to 8% in the South-South, 6.5% in the 
South-East and 10% in the North-Central.[3]
Nigeria is also endemic for hepatitis B virus (HBV) infection, 
the virus that shares similar transmission routes with HIV.[4] 
Over 2 billion of the world’s population have been exposed 
to HBV, and an estimated 387 million of these are now 
chronically infected with a rate of 10 million new carriers 
each year.[5] Approximately, 13% of the carriers will die from 
the consequences of the HBV infection with an overall annual 
mortality of about 1 million.[6] HBV is believed to be the main 
etiological factor in over 75% of chronic liver disease.[6]
Hepatitis C virus (HCV) is a single-stranded ribonucleic acid 
virus	 in	 the	 flaviviridae	 family	 and	 also	 a	major	 cause	 of	
liver disease in the world.[7] The overall prevalence of HCV 
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respectively. The HIV/HBV and HIV/HCV co‑infection prevalence rates were 0.24% (3/1239), 
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the prevalence of this infection among the most productive and economically viable age bracket.
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in Sub-Saharan Africa is 3%.[7] There are several routes of 
transmission of HCV but direct percutaneous inoculation 
is	 the	most	 efficient.[8] In South-Western Nigeria, a higher 
percentage of those with HCV infection had additional risk 
factors,	especially	scarification	marks.[9]
Syphilis is also a systemic disease caused by Treponema 
pallidum which can be spread by sexual contact, blood 
transfusion, and via vertical transmission.[10] Syphilis can 
seriously complicate pregnancy and result in spontaneous 
abortion, prematurity, low birth weight, stillbirth as well 
serious sequelae in live born infected children.[11]
Due to the similarity in the routes of transmission, many 
individuals have been exposed to HIV, HBV, HCV, and syphilis 
infection in various combinations. A study on blood donors 
showed that seroprevalence of HIV, HBV, HCV, and syphilis 
was 3.8%, 4.7%, 0.7%, and 1.3%, respectively.[12] Among 
those with co-infections, the most common combinations 
were HIV-syphilis 38% and HIV-HBV 34%.[12] These 
co-infections have been associated with reduced survival, 
drug-related hepatotoxicity, drug resistance, cross-resistance, 
and sub-optimal response.[13,14]
There are worldwide variations in seroprevalence of these 
infections depending on geographic area, risk groups, and the 
type of exposure involved.[4]
This study is aimed at estimating the seroprevalence of HIV, 
HBV, HCV, syphilis, and co-infections among antenatal 
women in Enugu, South-East Nigeria. The outcome will help 
in formulating intervention policies aimed at curtailing the 
spread of these infections.
Materials and Methods
Study design
This was a retrospective study which covered the antenatal 
cases in the hospital between 1st May 2006 and 30th April 
2008. A total of 2500 pregnant women attended the antenatal 
clinic within the study period. All the antenatal records with 
complete sociodemographic variables, HIV, HBV, HCV, and 
syphilis	screening	results	were	used	for	the 	study.	All	antenatal	
women whose mothers were HBV or HIV carriers were 
excluded. The study was approved by the Ethics Committee 
of University of Nigeria Teaching Hospital (UNTH), Enugu. 
All the antenatal records were thoroughly reviewed, and 
1239 of them met the inclusion criteria while 1261 of them 
did not. A pretested data extraction form was used to obtain 
information on the socio demographic status, parity, screening 
for HIV, hepatitis B surface antigen (HBsAg), syphilis, and 
HCV from the antenatal records. The data were extracted by 
two trained assistants.
Hepatitis B surface antigen  and antibodies to HCV were 
determined using Clinotech diagnostic enzyme-linked 
immunosorbent (ELISA) test kits (Clinotech Laboratories, 
USA; Batch/Lot No. for HBsAg screening kit is F0416J2 
and F0106J2 for HCV). The test sensitivity is 100% and 
specificity 99.7% for both HbsAg and HCV test kits. 
Syphilis was screened with Veneral Disease Research 
Laboratory (Clinotech Biotech Inc., California; Batch/Lot No. 
F0731J4,	sensitivity	100%,	specificity	99.7%).	Antibodies	to	
T. pallidum	were	confirmed	with	T. pallidum hemagglutination 
test. Antibodies to HIV-1 and -2 were screened with Abott 
Determine and Immunocomb (Alere Medical Company, 
Limited, Japan; Batch/Lot No. 54921U100, sensitivity 100%, 
specificity	 99.5%).	All	 reactive	 samples	were	 confirmed	
using ELISA.
S ta t i s t i ca l  ana lys i s  was  ach ieved  us ing  SPSS 
version 17 (Chicago, IL, USA). Chi-square analysis was 




Out of 1239 antenatal women, 154 were HIV positive 
giving a seroprevalence rate of 12.4% (154/1239), 42 were 
HBV positive resulting in an HBV seroprevalence of 3.4% 
(42/1239), and 32 of them were positive to HCV antibodies 
with a seroprevalent rate of 2.6% (32/1239) [Table 1]. One of 
the pregnant women was T. pallidum hemoaggluitination assay 
positive with seroprevalence rate of 0.08% (1/1239).
Three out of 1239 women were both HIV and HBV positive 
with co-prevalent rate of 0.24% (3/1239) [Table 2]. As was 
shown by the Chi-square values in Table 2, there was no 
statistically	significant	difference	in	HBV	infection	between	
the HIV positive and negative antenatal women (2 = 2.745, 
df = 1, P = 0.09). Two women were both HIV and HCV 
positive with a seroprevalent rate of 0.16% (2/1239). 
Similarly,	in	Table	2,	there	was	no	statistically	significant	
difference in HCV infection between the HIV positive 
and negative women (2 = 2.867, df = 1, P = 0.09). The 
only patient who was T. pallidum hemoagglutination test 
positive was also HIV positive. There was no HBV, HCV, 
Table 1: Screening pattern of the antenatal women
Screening pattern of 
the women
Frequency Percentage
HIV screening pattern n=1239
Positive 154 12.4
Negative 1085 87.6
HBsAg screening pattern n=1239
Positive 42 3.4
Negative 1197 96.6
HCV screening pattern n=1239
Positive 32 2.6
Negative 1207 97.4
HIV: Human immunodeficiency virus, HCV: Hepatitis C virus, HBsAg: Hepatitis B surface 
antigen
Ikeako, et al.: Seroprevalence of HIV, HBV, HCV, syphilis and co‑infections among antenatal women
956 Annals of Medical and Health Sciences Research | Nov-Dec | Vol 4 | Issue 6 |
and syphilis co-infection in both HIV positive and negative 
antenatal women in Enugu.
The most predominant age group of the women was 21–30 years 
53.9% (669/1239). The mean (SD) of age was 30.1 (2.1) 
years [Table 3]. Four hundred and ninety-three 493/1239 
(39.8%) of the women were public/civil servants followed by the 
unemployed group 28.7% (356/1239). Table 3 also shows that 
most of the antenatal women 38.7% (479/1239) were multiparous.
Table 4 reveals that the unemployed group of the antenatal 
women and the Artisans constitute the bulk of the women that 
were seropositive to HIV, HBV, and HCV antibodies.
 Discussion
The overall seroprevalence of HIV, 12.4% among antenatal 
women in Enugu, recorded in this study is higher than the 
national HIV prevalence of 4.6% among pregnant women.[15] 
It is also higher when compared with the 7.8% reported in 
Minna and 8.6% in Anambra state, Nigeria.[16,17]
In North West Ethiopia, a seroprevalence of 9.6% for 
HIV-1 was observed among pregnant women receiving 
antenatal services at the University of Gondar Teaching 
Hospital.[14] The seroprevalence in this study is lower than 
the 26% seroprevalence reported in Swaziland.[18] The 
seroprevalence of HIV, 12.4% in this study could be due to 
the increased level of awareness among antenatal women in 
Enugu and environs on the Prevention of Mother to Child 
Transmission (PMTCT) of HIV/AIDS as well as the functional 
PMTCT program in UNTH, Enugu thereby attracting more 
HIV-positive pregnant women to book at UNTH.
The seroprevalence of HBV 3.4%, among the women, is lower 
than previous reports from Nigeria; 8.2% in Yola[19] and 5% 
in Niger Delta.[20] It is similar to 3.7% reported in Jimma, 
Ethiopia.[21] Higher prevalence was recorded among pregnant 
Sudanese 5% [22] and India women 3.07%.[23]
However, cross-study comparisons may be misleading because 
of the kits used for the assay of HBsAg. In our study, HBsAg 
was assayed by ELISA technique. The use of polymerase chain 
reaction (PCR) and antibodies sensitive to the hepatitis B core 
antigen has been shown to be more sensitive than the serological 
methods used in our study and PCR could detect about 10% 
of occult HBV infection.[24] In addition, the differences in the 
socio-demographic characteristics of the women should be 
taken into consideration in such comparisons.
The HCV antibody prevalence among the women in the study 
was 2.6%. This is in agreement with the overall seroprevalence 
of HCV in Sub-Saharan Africa 3%.[7] It is, however, higher 
than the result from Niger Delta, Nigeria 0.5%,[20] Iran 
0.98%,[25] and Sudan <1%.[22] These variations may be related 
to the differences in the modes of transmission which is 
influenced by sociocultural practices and environmental 
factors.[20] In a tertiary medical center in South-West Nigeria 
where	 over	 90.8%	of	 the	women	 had	 scarification	marks,	
a seroprevalence of 9.2% was reported.[9] The differences 
have also been attributed to the choice of serological tests to 
determine HCV prevalence especially in developing countries 
where intercurrent infections contribute to false-positive 
enzyme immunoassay results.[26]
From this study, the seroprevalence of syphilis among 
antenatal attendees in Enugu is 0.08%. The seroprevalence 
is lower than 0.13% recorded by Ozumba et al.[27] in the 
same hospital two decades ago. It is lower than the national 
average for syphilis in pregnant Nigeria women, 0.3%.[28] 
However, a higher prevalence of 10% was reported among 
pregnant women in Osogbo, South-Western Nigeria.[29] Among 
antenatal women in Gondar, Ethiopia, the seroprevalence was 
1%.[10] The variation is seroprevalence could be attributed 




Positive 3 151 154
Negative 39 1046 1085





Positive 2 152 154
Negative 30 1055 1085
Total 32 1207 1239
χ2=2.867, df=1, P=0.09
HIV: Human immunodeficiency virus, HBV: Hepatitis B virus, HCV: Hepatitis C virus
Table 3: Sociodemographic variables among the antenatal 
women







Public/civil servants 493 39.8
Trading 197 15.9
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to the differences in sexual practices and behavior. The 
seroprevalence of syphilis in Enugu is low and has declined 
over the past two decades. Similar observation was made in 
Ethiopia.[10] Early seeking of effective medical treatment for 
sexually transmitted infections among the largely literate urban 
antenatal women may explain the decline. The low prevalence 
has also been attributed to over-the-counter use of antibiotics 
for minor complaints and easy access to the drugs.[10]
The HIV and HBV co-infection prevalent rate was 0.24%. This 
is <0.7% reported in Anambra state.[17] In this study, 0.14% 
of the antenatal women were positive for HIV and HCV. The 
only woman who was positive for syphilis was also HIV 
positive and whether syphilis predisposed her to HIV and vice 
versa could not be ascertained. There was no HBV and HCV 
co-infection in both HIV positive and negative women, and 
this supported the study in Rwanda and Uganda[30] but varied 
with the results from Malekan City, Iran.[25] The difference in 
HBV and HCV infection in both HIV-positive and negative 
antenatal	women	 in	Enugu	was	not	 statistically	 significant.	
On the contrary, a study conducted in Addis Ababa, Ethiopia 
showed that higher prevalence of HCV antibodies was seen 
among HIV positive compared to HIV negative antenatal 
attendees (2.9% vs. 0.87%, respectively).[31] The absence of 
HCV and HBV infection in both HIV negative and positive 
women may be due to the absence of such risk factors as 
injection	drug	use	commonly	seen	in	the	West	and	scarification	
marks that are not common in our area of study.
The age group of 21–40 years had the predominant HIV, 
HBV, and HCV prevalence and this supported the studies in 
Northwest Ethiopia.[10] This calls for concerted efforts aimed at 
preventive measures to reduce risky lifestyle practices among 
the most productive and economically viable age bracket.[13]
The unemployed group and artisans similarly had the highest 
seroprevalence of HIV, HBV, and HCV. A similar observation 
in Anambra State, Nigeria[17] showed that the occupation of the 
antenatal	women	influenced	the	infection	of	the	women.	Low	
socioeconomic factor initiates multiple sexual partnership, 
unprotected sex, and predisposes to sexually transmitted 
infections.[32]
The study has a number of limitations. This is an institutional 
study conducted in an urban area and consisted of only pregnant 
women who were able to access hospital; for this reason, the 
seroprevalence reported here maybe a lower estimate of the true 
prevalence among pregnant women in Enugu. The rate might 
be higher in individuals who had lower socioeconomic status 
such that they could not even reach a hospital from the rural 
area. No data are available for such risk factors as residence 
and place of birth. The size of the population is small, and it 
will not be possible to generalize the outcome of the study.
Conclusion
HIV, HBV, and HCV infection are a major global health 
problem necessitating a high priority in their prevention 
and control. There is a need for effective health education 
on behavioral change as well as the inclusion of HBV 
immunization for women of reproductive age to reduce the risk 
of spread to neonates through mother to child transmission. 
The low seroprevalence of syphilis observed in this study 
should not engender complacency in view of the deleterious 
effect of untreated maternal infection on pregnancy outcome 
and spread of HIV.
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